A new drug compound could combat tough-to-treat melanoma
Melanoma is commonly caused by the damaging effects of ultraviolet light—from sources like sunlight and tanning beds—on the DNA of skin cells. This UV damage can activate genes that encourage precancerous cells to further mutate into full-blown skin cancer. At the same time, UV damage can turn off other genes that would normally prevent tumor growth. With enough wrongly flipped switches, cancer can flourish. And melanoma is certainly flourishing. This year alone, 96,480 new instances of melanoma will be diagnosed in the United States and 7,230 Americans will die from the disease.
With so many people affected by melanoma, scientists are on the hunt for better ways to screen for melanoma risk and treat the most lethal types of skin cancer. One particularly voracious type of melanoma, caused by mutation of a gene called NRAS (which instructs cells to produce a protein of the same name, NRAS), drives 25 percent of skin cancers.
“There are immunotherapies and targeted therapies that have shown huge improvements for patients with melanoma,” said Rutao Cui, a Boston University School of Medicine professor of pharmacology and dermatology. “However, for patients with NRAS mutations, they don’t have very useful or very effective treatment strategies.”
Now, an international research team led by Cui has discovered a new way to stop the progression of melanoma by NRAS mutations with the flip of a genetic switch. Their findings were published January 31, 2019, in Cell.
Inside our bodies, proteins like NRAS play the role of dominoes, interacting with one another to switch other important gene activities on or off. The researchers set out in search of a way to interrupt the process in which mutated NRAS can instigate the growth of skin cancer. Since targeting the NRAS gene—just one of several dominoes in this type of skin cancer pathway—has proven to be so difficult, the researchers were determined to find another approach.
For NRAS to trigger cancer development, it first needs to be activated by another protein in the body. Until now, it’s been unknown exactly which protein is responsible for activating NRAS. But after testing the effect of several different proteins on the activity of NRAS, the team zeroed in on a likely culprit, a protein by the name of STK19.
STK19 is not a newly discovered protein in its own right, but its purpose has not been known until now. Cui’s team found that STK19 appears to work as an “on” switch for NRAS—activating production of NRAS proteins which, in turn, trigger the toppling of several other genetic dominoes downstream.
The researchers also found that, unlike NRAS, they could disable the STK19 gene and greatly diminish its ability to set the skin cancer sequence in motion.
Together, the team designed a new drug compound to shut down the effect of STK19 on NRAS. Then, testing its effect on skin cells cultured in petri dishes and in animal models, they proved that their compound can block NRAS activation and prevent melanoma from developing.
Cui says that this result is exciting not just for melanoma, but for other cancers as well. While the relationship between STK19 and NRAS may be particular to skin cancer, the approaches the team used to identify and block key activating proteins can be applied to find new treatments for similarly difficult-to-cure cancers.
Now the research team is looking to take their research to clinical trials to test out the STK19 inhibitor in humans, and hopefully, someday make it available as a targeted therapy to combat NRAS-driven melanomas.
In the meantime, Cui says that much work still needs to be done to not only create better and more precise treatments for patients suffering with melanoma, but also to alert vulnerable populations about the risk factors associated with the cancer.
“We need more monitoring for early diagnosis and full-body examinations for problematic spots,” says Cui, “and more proactive strategies for patients [at the highest risk of developing melanoma] to prevent cancer progression and metastasis.”
Learn more: Shutting Down Skin Cancer
The Latest on: Skin cancer
via Google News
The Latest on: Skin cancer
- State-of-the-art Skin Cancer Treatment In Bayon February 27, 2021 at 5:10 pm
The launch of a new dermatology practice offering the ‘gold standard’ in skin cancer treatment was celebrated with nibbles and mocktails on Wednesday [February 24]. Specialist dermatologist and ...
- Check the common signs of cancer to give yourself and your family an MOTon February 27, 2021 at 4:27 pm
FINDING and treating cancer early saves lives – fact. But as coronavirus continues to put pressure on the NHS, there are fears that those with symptoms are putting off a visit to their GP, with 3 ...
- Free skin cancer screening offered by appointment in Tri-Citieson February 27, 2021 at 11:58 am
A Tri-Cities dermatology office is making appointments for free skin cancer screenings Friday, March 5. DermaHealth Dermatology and Dermasurgery at 1295 Fowler St., Suite 1B, in Richland is offering ...
- Vitamin B3 Can Reverse Signs of Aging, Lower Cholesterol, and Reduce Your Risk of Skin Canceron February 26, 2021 at 11:30 am
When it comes to vitamins and minerals that are great for skin health, you’ve probably heard a lot about things like vitamin C and collagen in recent years. But now, vitamin B3 is quickly gaining ...
- Eight Skin Cancer Myths You Need To Stop Believingon February 25, 2021 at 11:30 am
A board-certified dermatologist debunks the most common misconceptions about skin cancer, to help you better protect yourself against the potentially fatal disease.
- Skin Cancer Diagnostics Therapeutics Market to Witness a Healthy Growth during 2020 to 2027 |Ameco Researchon February 25, 2021 at 2:28 am
A fresh report titled "Skin Cancer Diagnostics Therapeutics Market " has been presented by Ameco Research. It evaluates the key market trends, advantages, and factors that are pushing the overall ...
- CAFC Reverses In-Part, Vacates In-Part PTAB Patentability Finding for Skin Cancer Detection Deviceon February 25, 2021 at 12:23 am
On February 18, the CAFC issued a precedential opinion in an appeal by Canfield Scientific, Inc. from the decision of the Patent Trial and Appeal Board on inter partes review of U.S. Patent No. 7,359, ...
- MAFS Australia’s Lauren Reveals She Had Nose Job After Pimple Turned Out To Be Skin Canceron February 23, 2021 at 4:14 am
Married At First Sight Australia star Lauren Huntriss has revealed she had surgery on her nose after a suspicious pimple turned out to be skin cancer. Lauren opened up about the diagnosis on Instagram ...
- New insights on how inflammatory molecule contributes to skin and pancreatic cancerson February 22, 2021 at 1:19 pm
Chronic inflammation drives the development of various cancers, including those of the skin, colon and pancreas. Investigators at Massachusetts General Hospital (MGH) who previously demonstrated high ...
- Researchers Discover How Inflammatory Molecule Contributes to Skin and Pancreatic Cancerson February 21, 2021 at 6:35 pm
The molecule, interleukin-33, activates signals in a cell's nucleus to promote abnormal growth. Chronic inflammation drives the development of various cancers, including those of the skin, colon and ...
via Bing News